Cargando…

New pharmacological strategies to fight enveloped viruses

Enveloped viruses pose an important health threat because most of the persistent and many emerging viruses are enveloped. In particular, newly emerging viruses create a need to develop broad-spectrum antivirals, which usually are obtained by targeting host cell factors. Persistent viruses have devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wisskirchen, Karin, Lucifora, Julie, Michler, Thomas, Protzer, Ulrike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112871/ https://www.ncbi.nlm.nih.gov/pubmed/25108320 http://dx.doi.org/10.1016/j.tips.2014.06.004

Ejemplares similares

Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins
por: Debelec-Butuner, Bilge, et al.
Publicado: (2022)

Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro
por: Xia, Yuchen, et al.
Publicado: (2017)

Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing Data
por: Velkov, Stoyan, et al.
Publicado: (2020)

The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping Data
por: Velkov, Stoyan, et al.
Publicado: (2018)

Hepatitis-D Virus Infection Is Not Impaired by Innate Immunity but Increases Cytotoxic T-Cell Activity
por: Altstetter, Sebastian Maximilian, et al.
Publicado: (2021)

Depletion of T cells via Inducible Caspase 9 Increases Safety of Adoptive T-Cell Therapy Against Chronic Hepatitis B
por: Klopp, Alexandre, et al.
Publicado: (2021)

Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein
por: Sautto, Giuseppe A, et al.
Publicado: (2016)

PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis B
por: Bunse, Till, et al.
Publicado: (2022)

Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use
por: Wisskirchen, Karin, et al.
Publicado: (2017)

Virus strategies for passing the nuclear envelope barrier
por: Kobiler, Oren, et al.
Publicado: (2012)

One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors
por: Schiwon, Maren, et al.
Publicado: (2018)

Control of Hepatitis B Virus by Cytokines
por: Xia, Yuchen, et al.
Publicado: (2017)

Fighting Cancer with Mathematics and Viruses
por: Santiago, Daniel N., et al.
Publicado: (2017)

Targeting Cell Entry of Enveloped Viruses as an Antiviral Strategy
por: Teissier, Elodie, et al.
Publicado: (2010)

Hepatitis B Virus Impairs TLR9 Expression and Function in Plasmacytoid Dendritic Cells
por: Vincent, Isabelle E., et al.
Publicado: (2011)

Characterization of a library of 20 HBV-specific MHC class II-restricted T cell receptors
por: Schreiber, Sophia, et al.
Publicado: (2021)

Fighting antibiotic resistance—strategies and (pre)clinical developments to find new antibacterials
por: Walesch, Sebastian, et al.
Publicado: (2022)

Metabolic Remodelling: An Accomplice for New Therapeutic Strategies to Fight Lung Cancer
por: Mendes, Cindy, et al.
Publicado: (2019)

Strategies for fighting pandemic virus infections: Integration of virology and drug delivery
por: Nakamura, Takashi, et al.
Publicado: (2022)

Blocking sense‐strand activity improves potency, safety and specificity of anti‐hepatitis B virus short hairpin RNA
por: Michler, Thomas, et al.
Publicado: (2016)

Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts
por: Faure-Dupuy, Suzanne, et al.
Publicado: (2017)

Ultraviolet Light Fights New Virus
por: Mackenzie, Dana
Publicado: (2020)

Innate Antiviral Immune Responses to Hepatitis B Virus
por: Ait-goughoulte, Malika, et al.
Publicado: (2010)

Breaking the Mold: New Strategies for Fighting Aflatoxins
por: Schmidt, Charles W.
Publicado: (2013)

New small-molecule drug design strategies for fighting resistant influenza A
por: Shen, Zuyuan, et al.
Publicado: (2015)

Selected strategies to fight pathogenic bacteria
por: Plotniece, Aiva, et al.
Publicado: (2023)

Comprehensive Overview on Multiple Strategies Fighting COVID-19
por: Khalifa, Shaden A. M., et al.
Publicado: (2020)

Nanomedicine as a strategy to fight thrombotic diseases
por: Varna, Mariana, et al.
Publicado: (2015)

Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure
por: Allweiss, Lena, et al.
Publicado: (2023)

Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris
por: Billamboz, Muriel, et al.
Publicado: (2021)

New pharmacological strategies in rheumatic diseases
por: Schiotis, RE, et al.
Publicado: (2016)

Fusion of Enveloped Viruses in Endosomes
por: White, Judith M., et al.
Publicado: (2016)

Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers
por: Shoaib, Shoaib, et al.
Publicado: (2023)

New filter coating helps fight viruses
Publicado: (2021)

Erratum: “Breaking the Mold: New Strategies for Fighting Aflatoxins”
Publicado: (2014)

New Strategies to Fight against Sarcopenia at Old Age
por: Meynial-Denis, Dominique, et al.
Publicado: (2012)

Evaluation of Three New Strategies to Fight Obesity in Families
por: Luley, C., et al.
Publicado: (2010)

China's new strategy for fighting misconduct in academic journals
por: Lu, Jian-Ping
Publicado: (2019)

Exploitation of glycosylation in enveloped virus pathobiology
por: Watanabe, Yasunori, et al.
Publicado: (2019)

Giant virus vs amoeba: fight for supremacy
por: Oliveira, Graziele, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3325irje7rlm4asmcco4p7h8bt